Sinopharm
1099.HK
S$3.01
Share price
0.00%
Change (1 day)
-13.98%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Sinopharm (1099.HK) - Total liabilities
Total liabilities on the balance sheet as of December 2024 : S$46.71 Billion
According to Sinopharm's latest financial reports the company's total liabilities are S$46.71 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Sinopharm - Total liabilities on balance sheet (from 2008 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | S$49.15 B | -0.72% |
| 2022-12-31 | S$49.50 B | -1.02% |
| 2021-12-31 | S$50.01 B | 11.44% |
| 2020-12-31 | S$44.88 B | 20.54% |
| 2019-12-31 | S$37.23 B | 11.92% |
| 2018-12-31 | S$33.27 B | 21.92% |
| 2017-12-31 | S$27.29 B | 15.69% |
| 2016-12-31 | S$23.58 B | 9.68% |
| 2015-12-31 | S$21.50 B | 9.12% |
| 2014-12-31 | S$19.71 B | 22.52% |
| 2013-12-31 | S$16.08 B | 40.98% |
| 2012-12-31 | S$11.41 B | 17.23% |
| 2011-12-31 | S$9.73 B | 83.06% |
| 2010-12-31 | S$5.31 B | 38.91% |
| 2009-12-31 | S$3.82 B | 43.46% |
| 2008-12-31 | S$2.66 B | 15.9% |
| 2007-12-31 | S$2.30 B | 30.21% |
| 2006-12-31 | S$1.76 B |